Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.

Name: Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.
Creator: Emmanuel Sánchez-Meza
Published: 2022-01-17T22:19:19.957Z
Keywords: Dermatology, Dutasteride, Androgen Inhibitor, Alopecia

Sánchez-Meza, Emmanuel; Ocampo-Candiani, Jorge; Gómez-Flores, Minerva; Herz-Ruelas, Maira Elizabeth; Ocampo-Garza, Jorge; Orizaga-y-Quiroga, Thelma Laura; Martínez-Moreno, Adrian; Ocampo-Garza, Sonia Sofía

doi:10.17632/pv5t9kr58z.1

Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.

Published: 17 January 2022| Version 1 | DOI: 10.17632/pv5t9kr58z.1

Contributors:

Emmanuel Sánchez-Meza, Jorge Ocampo-Candiani, Minerva Gómez-Flores, Maira Elizabeth Herz-Ruelas, Jorge Ocampo-Garza, Thelma Laura Orizaga-y-Quiroga, Adrian Martínez-Moreno, Sonia Sofía Ocampo-Garza

Description

Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study. JAAD Supplemental Figure 1.A-B.

Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.

Description

Files

Categories

Licence